Via Bloomberg:
"The Scottsdale, Arizona-based company plans to start selling the drug for aesthetic uses in the U.S. within 30 to 60 days. Approval will trigger a $75 million payment to Ipsen, which developed the drug. The Boulogne Billancourt, France-based company said it will handle sales for cervical dystonia, beginning in the second half of this year.
Dysport may be priced 15 percent lower than Botox, helping it take almost a third of the cosmetic market over time, said Gary Nachman, an analyst at Leerink Swann & Co. in New York, in a phone interview last month. He estimates annual sales of Dysport for aesthetic uses will be $160 million by 2012."
BNET is reporting that Allergan is scrambling with seminars emphasizing that Botox and Reloxin are not interchangeable.
Disclaimer: I am on the Reloxin advisory board.
We'll let you know when Reloxin is available in Boca Raton and in New York and New Jersey!
Dr. Jason Pozner
Sanctuary Medical Aesthetic Center
Sanctuary Plastic Surgery
Dr. David J. Goldberg
Sanctuary Medical Aesthetic Center
Skin Laser Surgery Specialists of NY/NJ
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment